glp-1 peptides for weight loss Supplement Management & Cravings – Sunmed CBD Peptide Weight Loss Program -

NCT04093752) and insulin lispro (ClinicalTrials.gov registration no

Serious/Rare Risks: Pancreatitis, gallbladder issues (a known risk with rapid weight loss), and modest increases in resting heart rate

When to seek medical advice : Patients should contact their GP, diabetes specialist nurse, or NHS 111 urgently if they experience: Severe, persistent abdominal pain, especially if radiating to the back (possible pancreatitis) Persistent vomiting (unable to keep down fluids for more than 24 hours) Signs of dehydration (extreme thirst, dry mouth, reduced urination, dizziness) Fever, jaundice, or right upper abdominal pain (possible gallbladder disease) If nausea significantly impacts their ability to maintain adequate nutrition These symptoms may warrant dose reduction, temporary treatment interruption, or switching to an alternative GLP-1 preparation with a potentially better tolerability profile

Medication is compounded and shipped

It does not show any serious side effects and has been found to be neutral on the skin

As of March 2025, 11 states cover GLP-1s for weight loss under their state employee health plan, nine states provide coverage under their state Medicaid program, and five states provide coverage under both programs